Intermolecular (IMI) prices IPO

November 18, 2011 – GLOBE NEWSWIRE — Intermolecular Inc. (Nasdaq:IMI) priced its initial public offering of 9,650,000 shares of common stock at a public offering price of $10.00 per share. Intermolecular common stock will begin trading on The NASDAQ Global Select Market today under the symbol "IMI."

Of the 9,650,000 shares of common stock being offered to the public, 5,681,796 shares are being offered by Intermolecular, and the selling stockholder identified in the prospectus is offering an additional 3,968,204 shares. Intermolecular will not receive any proceeds from the sale of the shares by the selling stockholder.

In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,447,500 shares of common stock to cover over-allotments, if any. Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Barclays Capital Inc. are acting joint book-running managers for the offering. Pacific Crest Securities LLC and Needham & Company, LLC are serving as co-managers.

Intermolecular accelerates research and development, innovation, and time-to-market for the semiconductor and clean-energy industries, using the company’s high productivity combinatorial (HPC) platform and multi-disciplinary team. The company was founded in 2004 in San Jose, CA. Learn more at www.intermolecular.com.

The initial public offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from Morgan Stanley & Co. LLC, Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, by phone at 1-866-718-1649, or by email at prospectus@morganstanley.com, from J.P.

Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by phone at 1-866-803-9204, or from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by phone at
1-888-603-5847 or by email at Barclaysprospectus@broadridge.com.

A registration statement (including the prospectus) relating to these shares of Intermolecular common stock filed with the U.S. Securities and Exchange Commission was declared effective on November 17, 2011. Copies of the registration statement, as amended, can be accessed through the SEC’s website at www.sec.gov.

Subscribe to Solid State Technology

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

NEW PRODUCTS

Entegris announces GateKeeper GPS platform
07/15/2014Entegris, Inc., announced last week the launch of GateKeeper GPS, its next-generation of automated regeneration gas purification system (GPS) technology....
Bruker introduces Inspire nanoscale chemical mapping system
07/15/2014Bruker today announced the release of Inspire, the first integrated scanning probe microscopy (SPM) infrared system for 10-nanometer spatial...
MEMS wafer inspection system from Sonoscan
06/25/2014Sonoscan has announced its AW322 200 fully automated system for ultrasonic inspection of MEMS wafers....